Noninvasive Assays of Human Oocytes and Preimplantation Embryos (SBIR [R43])

The summary for the Noninvasive Assays of Human Oocytes and Preimplantation Embryos (SBIR [R43]) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Noninvasive Assays of Human Oocytes and Preimplantation Embryos (SBIR [R43])
	CFDA Number:	93.865
	CFDA Description:	Child Health and Human Development Extramural Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health Income Security and Social Services
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-HD-09-025
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	May 01, 2009
	Creation Date:	May 01, 2009
	Original Closing Date for Applications:	Nov 10, 2009
	Current Closing Date for Applications:	Nov 10, 2009
	Archive Date:	Dec 11, 2009
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	$300,000
	Federal Grant Award Ceiling:	$100,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Information not provided
Grant Description: Purpose. This Funding Opportunity Announcement (FOA) solicits Small Business Innovative Research (SBIR) grant applications from small business concerns (SBCs) that propose to establish high resolution, non-invasive assays of single human oocytes and preimplantation embryos that will serve to evaluate the quality and developmental potential of oocytes or embryos produced by in vitro fertilization laboratories. The assays must have certain features such as rapidity, low expense, simple laboratory manipulations and a high level of accuracy. A major goal of this initiative is to encourage and increase the use of single embryo transfers for assisted reproduction. This would reduce health risks to the mother and the offspring that result from multiple pregnancies, thereby reducing the high medical costs associated with these adverse outcomes. Mechanism of Support. This FOA will utilize the SBIR (R43) grant mechanism for Phase I applications and runs in parallel with a FOA of identical scientific scope, RFA-HD-09-024, which solicits applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/rfa-hd-09-025.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Biomedical/Biobehavioral Research Administration Development (BRAD) Award [G11]; • Rehabilitation Research Career Development Programs (K12); • Pediatric Scientist Development Program (PSDP) [K12]; • Translational Research in Pediatric and Obstetric Pharmacology (R21); • Translational Research in Pediatric and Obstetric Pharmacology (R01); • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Preclinical Stud...; • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Preclinical Stud...; • REPRODUCTIVE GENETICS AND EPIGENETICS; • DEVELOPMENTAL MECHANISMS OF HUMAN STRUCTURAL BIRTH DEFECTS; • ENDOMETRIAL CELL FUNCTION